Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IMMX

Immix Biopharma, Inc.

CIK 0001873835 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$13.66
↑ 0.50 (3.80%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$972.46M
P/E Ratio
-24.36
EPS
-0.89
Dividend Yield
Not covered
52W Position
99%
Beta
1.53

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.25
P/S
Not covered
EV/Revenue
Not covered
ROE
-17.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%
$1.94$13.76

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$29.44M
Total Assets
$104.84M
Free Cash Flow
-$24.66M

Recent news